Media Advisory: NIH Director visits Ohio State to discuss opioid crisis
COLUMBUS, Ohio – Francis Collins, director of the National Institutes of Health will be at Ohio State on March 22 to talk with university researchers about combatting the opioid and addiction crisis.
Collins will participate in a roundtable discussion with researchers and other experts at 10 a.m. in the Patricia & Steven Gabbe Conference Room (L045) in The James Cancer Hospital, 460 W. 10th Ave.
Following the roundtable discussion, the inaugural winners of Ohio State’s new Opioid Innovation Fund grants will be announced at 11:30 a.m. in room B050 at the James.
Media are encouraged to attend both events. Collins and others will be available for interviews following the Opioid Innovation Fund announcement.
Parking is available in the South Cannon Garage, 1640 Cannon Dr.
Collins was sworn in as the 16th director of the NIH on Aug. 17, 2009. A physician-geneticist noted for his landmark discoveries of disease genes and leadership of the international Human Genome Project, he oversees the work of the largest supporter of biomedical research in the world.
In 2017, Ohio State announced a commitment of more than $1 million to the Opioid Innovation Fund to advance understanding of the crisis and inspire new, multidisciplinary partnerships that address the epidemic.
WHAT: Roundtable discussion followed by announcement of winners of Ohio State University Opioid Innovation Fund grants.
WHO: Roundtable: Francis Collins, director of the National Institutes of Health; Roger Rennekamp, associate dean and director, OSU Extension; Rebecca Jackson, professor, Division of Endocrinology, Diabetes and Metabolism; Ayaz Hyder, assistant professor, Division of Environmental Health Sciences, College of Public Health; Julie Teater, clinical psychiatrist, Department of Psychiatry; and others.
Opioid Innovation Fund: Francis Collins, director of the National Institutes of Health; William Martin, dean of the College of Public Health; and grant winners.
WHEN: Roundtable: 10 a.m. on Thursday, March 22
Opioid Innovation Fund: 11:30 a.m. on Thursday, March 22
WHERE: James Cancer Hospital, 460 W. 10th Ave., rooms L045 and B050